DK0424043T3 - Flydende vandigt ophthalmisk præparat, der overgår fra væske- til gelfase - Google Patents

Flydende vandigt ophthalmisk præparat, der overgår fra væske- til gelfase

Info

Publication number
DK0424043T3
DK0424043T3 DK90311208.4T DK90311208T DK0424043T3 DK 0424043 T3 DK0424043 T3 DK 0424043T3 DK 90311208 T DK90311208 T DK 90311208T DK 0424043 T3 DK0424043 T3 DK 0424043T3
Authority
DK
Denmark
Prior art keywords
liquid
gel phase
passes
aqueous ophthalmic
ophthalmic preparation
Prior art date
Application number
DK90311208.4T
Other languages
Danish (da)
English (en)
Inventor
Gilles Chastaing
Original Assignee
Merck Sharp & Dohme Chibret Sn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Chibret Sn filed Critical Merck Sharp & Dohme Chibret Sn
Application granted granted Critical
Publication of DK0424043T3 publication Critical patent/DK0424043T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90311208.4T 1989-10-17 1990-10-12 Flydende vandigt ophthalmisk præparat, der overgår fra væske- til gelfase DK0424043T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913534A FR2653021A1 (fr) 1989-10-17 1989-10-17 Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.

Publications (1)

Publication Number Publication Date
DK0424043T3 true DK0424043T3 (da) 1993-06-21

Family

ID=9386463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90311208.4T DK0424043T3 (da) 1989-10-17 1990-10-12 Flydende vandigt ophthalmisk præparat, der overgår fra væske- til gelfase

Country Status (9)

Country Link
EP (1) EP0424043B1 (fr)
JP (1) JP3043795B2 (fr)
AT (1) ATE89745T1 (fr)
CA (1) CA2027630C (fr)
DE (1) DE69001739T2 (fr)
DK (1) DK0424043T3 (fr)
ES (1) ES2055339T3 (fr)
FR (1) FR2653021A1 (fr)
IE (1) IE64045B1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141502T1 (de) * 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
JP2536806B2 (ja) * 1991-03-27 1996-09-25 アルコン ラボラトリーズ インコーポレイテッド ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6331540B1 (en) 1999-11-01 2001-12-18 Alcon Universal Ltd. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
ES2225573T3 (es) 2000-07-28 2005-03-16 Alcon, Inc Composiciones farmaceuticas que contienen tobramicina y goma xantana.
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US7060297B2 (en) 2000-11-06 2006-06-13 Alcon, Inc. Carrageenan viscoelastics for ocular surgery
JP2005521690A (ja) 2002-02-22 2005-07-21 ファルマシア・コーポレーション ゴム系を含む眼科用製剤
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
WO2011018800A2 (fr) 2009-08-13 2011-02-17 Fdc Limited Nouvelle solution formant un gel in situ pour l’administration de médicaments par voie oculaire
RS58731B1 (sr) * 2014-01-22 2019-06-28 Visufarma B V Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa
MX2018000285A (es) 2015-07-14 2018-02-19 Marinomed Biotech Ag Composicion para desobstruir la nariz congestionada que tiene actividad antiviral.
CN109752557B (zh) * 2017-11-06 2021-06-08 清华大学 检测生物分子间相互作用及其调控因子的成套试剂与应用
DE202022102900U1 (de) 2022-05-25 2023-01-13 Anant Narayanrao Deshpande Tetrahydrocurcumin niosomales in-situ-Gel für okulare Arzneimittelabgabe

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3601132A1 (de) * 1986-01-16 1987-07-23 Christian Bannert Verfahren zur behandlung der schleimhaut
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide

Also Published As

Publication number Publication date
JP3043795B2 (ja) 2000-05-22
EP0424043B1 (fr) 1993-05-26
JPH03133936A (ja) 1991-06-07
CA2027630A1 (fr) 1991-04-18
IE64045B1 (en) 1995-06-28
ES2055339T3 (es) 1994-08-16
FR2653021A1 (fr) 1991-04-19
EP0424043A1 (fr) 1991-04-24
CA2027630C (fr) 2001-04-24
DE69001739T2 (de) 1993-11-25
ATE89745T1 (de) 1993-06-15
IE903713A1 (en) 1991-04-24
DE69001739D1 (de) 1993-07-01

Similar Documents

Publication Publication Date Title
DK0424043T3 (da) Flydende vandigt ophthalmisk præparat, der overgår fra væske- til gelfase
DK183386A (da) Sucralfatsuspension
SE8803570D0 (sv) 4h-1-bensopyran-4-on-derivat eller dess salt, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande detsamma som aktiv komponent
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
FI942573A (fi) Koostumus, joka käsittää hyytymistekijä VIII -formuloinnin, sen valmistusmenetelmä ja pinta-aktiivisen aineen käyttö stabilointiaineena
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
DK55784A (da) Xylanderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende xylanderivaterne med antithrombose- og hypolipidaemisk virkning
IT8620939A0 (it) Processo per la preparazione di (2,2)-paraciclofano e suoi derivati.
FI925649A0 (fi) Karboxivinylpolymerer med newtonsk viskositet
IT8222784A0 (it) Processo per la preparazione di derivati dell'insulina.
PT88150A (pt) Processo para a preparacao de uma composicao farmaceutica combinada contendo um polissacarido sulfatado e um derivado de xantina
DE69129747T2 (de) In lösung bringen von proteinen in aktiver form
NO178028C (no) Fremgangsmåte ved fremstilling av 3-(L-pyroglutamyl)-L-tiazolidin-4-karboksylsyre samt derivater derav
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
DE69033306D1 (de) Proteinkomplex
ES2044172T3 (es) Procedimiento de preparacion de microparticulas de colageno y productos obtenidos.
IT8919524A0 (it) Derivati dal 1 arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
IT8819683A0 (it) Oxo isoindolinil derivati otticamente attivi.
FR2698371B1 (fr) Procede de preparation de la forme leuco de colorants au soufre sous forme de particules.
IT8822558A0 (it) Soluzione farmaceutica acquosa per uso oftalmico.
ES238759Y (es) Articulacion de bola, especialmente articulacion soportadorapara la suspension de las ruedas delanteras de vehiculos au-tomoviles.
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.
IT8720271A0 (it) Nuovi derivati dell'ergolene, composizioni farmaceutiche che licontengono e procedimento per lapreparazione dei medesimi.
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.